Bachrodt Amy bought MAZE
January 2, 2026 · Form 4 insider transaction
Bachrodt Amy bought 204 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $2.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
204
Price
$10.42
Total value
$2.1K
InsiderBachrodt Amy
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after13,169
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.